These control samples corresponded to an engineered standard sample which harbored two well-characterized fusion transcripts, EML4-ALK (E6:A20) and CCDC6-RET (C1:R12), and the human lung cancer cell line H2228 (EML4-ALK; E6:A20). The gene discussed is EML4; the disease is lung carcinoma.